These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34582222)

  • 21. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
    dela Peńa IC; Ahn HS; Choi JY; Shin CY; Ryu JH; Cheong JH
    Behav Pharmacol; 2011 Feb; 22(1):31-9. PubMed ID: 21160423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rearing in an enriched environment attenuated hyperactivity and inattention in the Spontaneously Hypertensive Rats, an animal model of Attention-Deficit Hyperactivity Disorder.
    Botanas CJ; Lee H; de la Peña JB; Dela Peña IJ; Woo T; Kim HJ; Han DH; Kim BN; Cheong JH
    Physiol Behav; 2016 Mar; 155():30-7. PubMed ID: 26656767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-fostering differentially affects ADHD-related behaviors in spontaneously hypertensive rats.
    Gauthier AC; DeAngeli NE; Bucci DJ
    Dev Psychobiol; 2015 Mar; 57(2):226-36. PubMed ID: 25647439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior.
    Wultz B; Sagvolden T; Moser EI; Moser MB
    Behav Neural Biol; 1990 Jan; 53(1):88-102. PubMed ID: 2302145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
    Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
    Clin Ther; 2016 Mar; 38(3):595-602. PubMed ID: 26874787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
    Ueno K; Togashi H; Yoshioka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caffeine Consumption plus Physical Exercise Improves Behavioral Impairments and Stimulates Neuroplasticity in Spontaneously Hypertensive Rats (SHR): an Animal Model of Attention Deficit Hyperactivity Disorder.
    França AP; Schamne MG; de Souza BS; da Luz Scheffer D; Bernardelli AK; Corrêa T; de Souza Izídio G; Latini A; da Silva-Santos JE; Canas PM; Cunha RA; Prediger RD
    Mol Neurobiol; 2020 Sep; 57(9):3902-3919. PubMed ID: 32621279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder.
    Kim J; Park H; Yu SL; Jee S; Cheon KA; Song DH; Kim SJ; Im WY; Kang J
    Int J Dev Neurosci; 2016 Oct; 53():83-89. PubMed ID: 27469434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
    van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
    Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on head-to-head trials.
    Liu Q; Zhang H; Fang Q; Qin L
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):854-865. PubMed ID: 28052720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
    Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin for attention-deficit-hyperactivity disorder: a systematic review and preliminary behavioral investigation.
    de Sousa Macedo LLB; Antunes FTT; de Andrade Alvarenga W; Batista MCC; de Moura MSB; Farias MNL; Caminski ES; Dallegrave E; Grivicich I; de Souza AH
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):803-813. PubMed ID: 35394134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD.
    Guo T; Yang C; Guo L; Liu K
    Neurosci Lett; 2012 Oct; 528(1):11-5. PubMed ID: 22985505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of perinatal methylphenidate (MPH) treatment on postweaning behaviors of male and female Sprague-Dawley rats.
    Ferguson SA; Delbert Law C; Sahin L; Montenegro SV
    Neurotoxicol Teratol; 2015; 47():125-36. PubMed ID: 25514582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
    Dela Peña I; Kim BN; Han DH; Kim Y; Cheong JH
    Arch Pharm Res; 2013 Apr; 36(4):400-10. PubMed ID: 23471559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Golubchik P; Kodesh A; Weizman A
    Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany.
    Greven P; Sikirica V; Chen YJ; Curtice TG; Makin C
    Eur J Health Econ; 2017 Sep; 18(7):893-904. PubMed ID: 27817164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.